Navigation Links
Roka Bioscience Awarded AOAC-RI Certification for Roka Listeria Detection Assay
Date:1/17/2012

WARREN, N.J., Jan. 17, 2012 /PRNewswire/ -- Roka Bioscience announced today that their Roka Listeria Detection Assay has received AOAC Performance Tested Method(SM) certification from the AOAC Research Institute (AOAC-RI). The independent laboratory study testing was conducted by Silliker, Inc., as part of the AOAC-RI independent third-party evaluation and validation processes.

The Roka Listeria Detection Assay runs on the Atlas™ System, an innovative fully automated molecular instrument for the detection of food pathogens in food and environmental samples. This instrument utilizes a simple three-step procedure—Enrich, Transfer, Automate—and is capable of processing over 300 samples in 8 hours. The instrument's dynamic scalability and high throughput provides greater efficiency, flexibility, and freedom to meet the ever-increasing demands placed on food safety laboratories.

The initial menu for the Atlas System will be the Roka Listeria and Salmonella Detection Assays. Internal and external AOAC studies for the Roka Salmonella Detection Assay has been completed and submitted for AOAC Performance Tested Method Certification. Additional assays are currently in development.

"AOAC-RI certification of the Roka Listeria Detection Assay was a critical step for us," stated Paul Thomas, CEO and President of Roka Bioscience.  "This certification is recognized worldwide as the ultimate performance-based validation in our industry. We can now say with even more certainty that this assay, together with the Atlas System, gives food safety laboratories an ideal testing solution. Accuracy, speed, ease of use, flexibility—with this system, laboratories can truly have it all."

About AOAC-RI

The AOAC Research Institute (AOAC-RI) is a wholly owned subsidiary of AOAC INTERNATIONAL (AOAC) that administers AOAC's conformity assessment, including the AOAC Performance Tested Methods program.  AOAC is a globally recognized, independent, not-for-profit standards developing association founded in 1884. AOAC serves the analytical community by engaging industry stakeholders to develop voluntary consensus standards for methods and providing analytical methods that demonstrate confidence in analytical results. For more information on the AOAC-RI and AOAC, visit the AOAC website at www.aoac.org.

Roka Bioscience

Roka Bioscience is a privately held company focused on developing and commercializing innovative solutions based on molecular technologies for the industrial markets. The company's scientific platform is based on proven, proprietary technologies used widely in clinical diagnostic testing and now being introduced into food safety and other industrial markets. Roka's current product line provides food safety professionals with a fully automated molecular pathogen detection solution that delivers rapid, accurate results and improved laboratory efficiencies. For more information, visit www.rokabio.com.

Contact: 
Steve Sobieski
Chief Financial Officer 
(908) 605-4621
ssobieski@rokabio.com


'/>"/>
SOURCE Roka Bioscience
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Following receiving ... Israel , s AMAR is a major milestone ... M w ound care market in ... BST for inclusion in the National Health Basket ...   E-QURE Corp. (OTCQB: EQUR), a leader in ...
(Date:2/24/2017)... , Feb 24, 2017 Research and Markets ... and Strategies - 2016" report to their offering. ... The latest research Dry eye Drugs Price ... the global Dry eye market. The research answers the following questions: ... Dry eye and their clinical attributes? How are they positioned in the ...
(Date:2/24/2017)... Feb. 23, 2017 The U.S. Food ... PhenoTest BC Kit, performed on the Pheno System. ... that cause bloodstream infections and provide information about ... to (antibiotic sensitivity). The test also reduces the ... important information, which can guide antibiotic treatment recommendations ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare has long ... company involved in the underground testing of nuclear weapons. Years later, when her co-workers ... of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made by agencies ...
(Date:2/27/2017)... ... 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme ... Center for Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) ... has compiled into a single volume a compelling argument that the disease does exist ...
(Date:2/27/2017)... ... ... New Jersey ranks among the top five states in the entire nation ... advanced services is growing. , Project WE vs C is a focused two-year ... non-profit partners in their fight against cancer and in support of their shared mission ...
(Date:2/26/2017)... York (PRWEB) , ... February 26, 2017 , ... ... products for wholesale distribution in North America, today announced it would be offering ... The company, which prides itself on crafting quality and unique baby clothing/feeding products, ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... (PD) in persons with a specific LRRK2 mutation, according to a study released ... studies have provided evidence of a link between pesticides and incidence of sporadic ...
Breaking Medicine News(10 mins):